Brand / Medicines

Our Medicines

Download our Charter on the responsible medical use of opioid analgesics in pain management

Pain

BUPREDERMAL^® PATCH

buprenorphine

Product Information Consumer Medicine Information

MS MONO^® CAPSULES

modified release morphine sulfate

Product Information Consumer Medicine Information

NORSPAN^® PATCH

transdermal buprenorphine matrix patch

Product Information Consumer Medicine Information

ORDINE^® ORAL SOLUTION

immediate release morphine hydrochlorid

Product Information Consumer Medicine Information

OXYCONTIN^® TABLETS

modified release oxycodone hydrochloride

Product Information Consumer Medicine Information

OXYNORM^® CAPSULES AND LIQUID

immediate release oxycodone hydrochloride

Product Information for capsules and liquid Consumer Medicine Information for capsules Consumer Medicine Information for liquid

OXYNORM^® INJECTION

immediate release oxycodone hydrochloride

Product Information for injection Consumer Medicine Information

SEVREDOL^® TABLETS

immediate release morphine sulfate

Product Information Consumer Medicine Information

TARGIN^® TABLETS

modified release oxycodone and modified release naloxone hydrochloride dihydrate

Product Information Consumer Medicine Information

MS CONTIN^® TABLETS

modified release morphine sulfate

Product Information Consumer Medicine Information

DILAUDID^® TABLETS

immediate release hydromorphone hydrochloride

Product Information Consumer Medicine Information

DILAUDID^® & DILAUDID^®HP INJECTIONS

hydromorphone hydrochloride

Product Information for injection Consumer Medicine Information

^® MS MONO, NORSPAN, OXYCONTIN, OXYNORM, SEVREDOL, MS CONTIN, DILAUDID and TARGIN are registered trade marks.
^® ORDINE is a registered trade mark of Pfizer (Perth) Pty Ltd and is used under licence.

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at https://aems.tga.gov.au/

Adverse events can also be reported to Mundipharma at Drugsafety@mundipharma.com.au